drugset / Trial / NCT00429520

Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds

NCT00429520 ↗

Phase 4 Completed 114 enrolled Merz Pharmaceuticals GmbH
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.

Timeline

Start
2005-12
Primary completion
—
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject IMD1 basic Unknown — —

Indications

No indication recorded.